Table 3.

Kappa agreement of infection detection between sample types

			Result (Sample 1/Sample 2)
	Sample 1	Sample 2	Positive/ Positive	Positive/ Negative	Negative/ Positive	Negative/ Negative	Kappa	(95%CI)
hrHPV* N=193	Self-home†	Self-clinic‡	19	5	11	158	0.66	(0.49–0.80)
	Self-home	Clinician§	16	8	6	163	0.66	(0.46–0.80)
	Self-clinic	Clinician	16	14	6	157	0.56	(0.36–0.73)
TV || N=186	Self-home	Self-clinic	17	2	3	164	0.86	(0.71–0.96)
	Self-home	Clinician	17	2	2	165	0.88	(0.74–0.98)
	Self-clinic	Clinician	18	2	1	165	0.91	(0.80–1.00)
MG¶ N=181	Self-home	Self-clinic	8	1	2	170	0.83	(0.59–1.00)
	Self-home	Clinician	5	4	1	171	0.65	(0.27–0.92)
	Self-clinic	Clinician	6	4	0	171	0.74	(0.44–0.94)

^*hrHPV=high-risk human papillomavirus;

^†Self-home=cervico-vaginal sample self-collected at home;

^‡Self-clinic=cervico-vaginal sample self-collected in clinic,

^§Clinician=cervical sample collected by clinician;

^||TV= Trichomonas vaginalis;

^¶MG= Mycoplasma genitalium; 95%CI=95% confidence interval.

Analyses for each infection among women with available results for all three sample types.